Nebojša Stanković

Development of an Effective Palladium Removal Process for VEGF Oncology Candidate AG13736 and a Simple, Efficient Screening Technique for Scavenger Reagent Identification

Erik J. Flahive, Brigitte L. Ewanicki, Neal W. Sach et al. · Organic Process Research & Development · 2008 · 76 citations

Pharmacy, Medicinal Chemistry, Oncology +14

Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7′-substituents and initial pharmacokinetic assessments

Lian‐Sheng Li, Yuefen Zhou, Douglas E. Murphy et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 35 citations

Pharmacy, Medicinal Chemistry, Pharmacokinetics +16

5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase

Frank Ruebsam, Chinh Van Tran, Lian‐Sheng Li et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 29 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +13

Efficient synthesis of 2,6-disubstituted-5-hydroxy-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid ethyl esters

Douglas E. Murphy, Peter S. Dragovich, Benjamin K. Ayida et al. · Tetrahedron Letters · 2007 · 25 citations

Natural Sciences, Chemistry, Medicinal Chemistry +7

Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK properties

Maria V. Sergeeva, Yuefen Zhou, Darian M. Bartkowski et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 22 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15